Sorafenib response in hepatocellular carcinoma: MicroRNAs as tuning forks

Hepatocellular carcinoma (HCC) is the primary liver malignancy that contributes towards the second most common cause of cancer‐related mortality. The targeted chemotherapeutic agent, sorafenib, is known to show a statistically significant but limited overall survival advantage in advanced HCC. Howev...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Hepatology research 2018-01, Vol.48 (1), p.5-14
Hauptverfasser:	Kanthaje, Shruthi, Makol, Ankita, Chakraborti, Anuradha
Format:	Artikel
Sprache:	eng
Schlagworte:	Carcinogenesis Drug resistance Hepatocellular carcinoma Intracellular signalling Liver cancer Malignancy MicroRNAs miRNA Non-coding RNA resistance sorafenib Statistical analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!